False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care | Genetics in Medicine - 0 views
-
Nathan Goodyear on 09 Apr 18Consumers beware: direct to consumer genetic testing found to have 40% false positive rates with misclassification of variants. This also includes the interpretative reports that often accompany the direct to consumer genetic test companies or included from 3rd parties. This could have huge implications in the use of Epigenetics, pharmacogenetics, and Cancer genetics. These genetic testing needs medical interpretation not algorithms.